COLLEEN EICHER: Open Payments
NPI 1821766270 · HARTVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 64 payments from 34 companies in 2025. Trend: 2023 $330 · 2024 $1,036 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $150 |
| Eisai Inc. | 4 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| Genmab U.S., Inc. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $58 |
| Pharmacosmos Therapeutics Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $49 |
Products named: Lenvima, Stivarga, IMBRUVICA, MONOFERRIC, Tivdak, KEYTRUDA, KISQALI, Vyloy.
Industry payments across OH — which companies pay providers there.
